News on this topic
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - ICIJ
icij.org/investigations/cancer-calculus/merck-keytruda-cancer-drug-price/

About the Cancer Calculus investigation - ICIJ: How Merck keeps the price of its lifesaving cancer drug, Keytruda, sky-high, locking out patients and squeezing ...
icij.org/investigations/cancer-calculus/about-keytruda-cancer-calculus/

Frequently asked questions about the Cancer Calculus investigation - ICIJ: What is Keytruda? Why is it so expensive? The key findings of the Cancer Calculus ...
icij.org/investigations/cancer-calculus/faqs-keytruda-cancer-calculus/

Similar to This
Previous
Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
cnbc.com/2026/10/14/merck-moderna-cancer-vaccine-manufacturing-time.html

After cancer drug counterfeiting scandal, India imposes new tracing requirements - ICIJ
icij.org/investigations/cancer-calculus/after-cancer-drug-counterfeiting-scandal-india-imposes-new-tracing-requirements/

Merck takes Austria’s Keytruda price transparency battle to top court as journalists fight for information - ICIJ
icij.org/investigations/cancer-calculus/merck-takes-austrias-keytruda-price-transparency-battle-to-top-court-as-journalists-fight-for-information/

Senator questions Merck over patent strategy for blockbuster cancer drug Keytruda - ICIJ
icij.org/investigations/cancer-calculus/senator-questions-merck-over-patent-strategy-for-blockbuster-cancer-drug-keytruda/

Lowering doses of cancer drugs could slash global health spending by $30B, new research shows - ICIJ
icij.org/investigations/cancer-calculus/lowering-doses-of-cancer-drugs-could-slash-global-health-spending-by-30b-new-research-shows/

Mexico seizes suspicious Keytruda in raid to dismantle counterfeit medication ring - ICIJ
icij.org/investigations/cancer-calculus/mexico-seizes-suspicious-keytruda-in-raid-to-dismantle-counterfeit-medication-ring/

Patents, prices and court files: How ICIJ used data to investigate an industry that thrives on secrecy - ICIJ
icij.org/investigations/cancer-calculus/patents-prices-and-court-files-how-icij-used-data-to-investigate-an-industry-that-thrives-on-secrecy/

WATCH: Inside the Cancer Calculus investigation — a live Q&A - ICIJ: Go behind the scenes of the Cancer Calculus investigation, and hear insights about ...
icij.org/investigations/cancer-calculus/watch-inside-the-cancer-calculus-investigation-a-live-qa/
Following the paper trail to Guatemala to uncover what records can’t reveal about access to Keytruda - ICIJ
icij.org/investigations/cancer-calculus/following-the-paper-trail-to-guatemala-to-uncover-what-records-cant-reveal-about-access-to-keytruda/

Cancer drug "Keytruda": On the trail of the secret business: Why even the Ministry of Health doesn't know the price of the cancer drug that Austrian ...
profil.at/podcasts/wie-ein-pharmakonzern-den-preis-fuer-ein-krebs-medikament-diktiert/403154618

‘Unacceptable’: Lawmakers react to revelations from ICIJ’s Cancer Calculus investigation - ICIJ
icij.org/investigations/cancer-calculus/unacceptable-lawmakers-react-to-revelations-from-icijs-cancer-calculus-investigation/

A ‘burgeoning black market’, inflated dosing and the over-judicialization of health care: reporters around the world tell stories about Keytruda - ICIJ
icij.org/investigations/cancer-calculus/a-burgeoning-black-market-inflated-dosing-and-the-over-judicialization-of-health-care-reporters-around-the-world-tell-stories-about-keytruda/

Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump - ICIJ
icij.org/investigations/cancer-calculus/report-mercks-blockbuster-cancer-drug-topped-200000-a-year-under-trump/

Counterfeiters cash in on the world’s bestselling cancer drug - ICIJ: Desperate patients — and even hospitals — have become unwitting customers of fake Keytruda ...
icij.org/investigations/cancer-calculus/cancer-drug-counterfeits-keytruda-immunotherapy/

How Merck uses patents to help maintain Keytruda's exorbitant price - ICIJ: Explore the U.S. patents Merck deploys to stymie competition and keep revenues ...
icij.org/investigations/cancer-calculus/keytruda-evergreening-patents-merck/
‘They deny the medication that is keeping you alive’: Patients wage grueling legal battles for lifesaving cancer drug - ICIJ
icij.org/investigations/cancer-calculus/cancer-patients-legal-battle-keytruda-lifesaving-drug/

Cancer Calculus - ICIJ: How Merck keeps the price of its blockbuster cancer drug sky-high, shutting out patients and straining health care systems around the ...
icij.org/investigations/cancer-calculus/

How Merck keeps prices for its blockbuster cancer drug sky high: Merck built a wall of patents that keeps a cancer drug's price – and its profits – high ...
usatoday.com/story/money/2026/04/14/merck-keytruda-pricing-patents-dosage-drug-cost-cancer/89507794007/

Next
